Browsing "Endocrinology & Metabolism" by Keyword : Heart Failure

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 9 of 9

Pub YearTitleAuthor(s)
2018Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study김대중, 김혜진, 이관우, 한승진
2020Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study김대중, 하경화
2020Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study김대중, 하경화
2020Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study김혜진
2017Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study김대중, 김혜진, 박래웅, 윤덕용, 이관우, 한승진
2023Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study김대중, 하경화
2023Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia김대중, 하경화
2019Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study김대중, 하경화
2021Trends in cardiovascular complications and mortality among patients with diabetes in South Korea김대중, 하경화
1

Browse